KLOW80 APIlyophilized peptide|Raw material|GHK-Cu powder|BPC powder|KPV powder|TB500 powder|API
TDS 59 Inquiries
89030-95-5
Pharmaceutical Grade
99%
guangzhou
HKX
80mg
2027-02-01
Tirzepatide,Semaglutide,Retatrutide,MOTS-C,GHK-CU,MT-2
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionCopper Tripeptide is a tripeptide molecule rich in copper ions. Its sequence is GHK and it is widely present in human blood, saliva and urine. With age, the concentration of GHK gradually decreases, which is related to the decline of organ regeneration ability. Copper Tripeptide has strong antioxidant capacity, neutralizes free radicals, protects the skin from environmental damage, and with its unique copper ion affinity, it plays a role in promoting wound healing and activating skin regeneration.Certificates
-
TDS
Basic Info-
Product Name:
Copper tripeptide
Other Name:[N2-(N-Glycyl-L-histidyl)-L-lysinato(2-)]copper;Ghk-Cu/AHK-CU;Copper tripeptide (GHK-Cu);Prezatide copper,[N2-(N-Glycyl-L-histidyl)-L-lysinato(2-)]copper;tripeptide/GHK-Cu;Copper peptide, GHK-Cu, Copper tripeptide-1;GHK Copper;GHK.CU.HAC
CAS No.:89030-95-5
Molecular Formula:C14H21CuN6O4
InChIKeys:DDNUEECOCUBKBT-MIIMWFGWNA-L
Molecular Weight:400.91
Exact Mass:402.10800
EC Number:1308068-626-2
Color/Form:Light blue to blue
Categories:
Characteristics-
PSA:
186.03000
XLogP3:1.04530
Critical Temperature & Pressure:under inert gas (nitrogen or Argon) at 2–8 °C
Research-
Class:
Actin-sequestering protein / 43-amino-acid peptide
Status:Research compound — Not FDA approved (investigational: RGN-259 for dry eye / neurotrophic keratitis)
Mechanism:A naturally occurring 43-amino-acid peptide (Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser-OH) that binds G-actin (sequesters monomeric actin), preventing F-actin polymerization. Promotes cell migration, angiogenesis, wound healing, and anti-inflammatory responses via integrin-linked kinase (ILK) and HIF-1α/VEGF pathways. TB-500 is the synthetic fragment Ac-LKKTETQ (MW ~895) often sold under this CAS.
Activity note:Thymosin Beta-4 is an actin-binding protein, not a receptor agonist. Functional activity is measured by actin sequestration (Kd ~0.7–1 μM) and cell migration assays, not EC₅₀.
Source:Goldstein AL, et al. Vitam Horm. 2003;66:257–296. RegeneRx RGN-259 clinical program.DOI
Clinical Development:
References-
DrugBank:PubChem:UNII:Disclaimer:
Thymosin Beta-4 (TB-500) is NOT FDA-approved for human therapeutic use. RGN-259 (Tβ4 ophthalmic solution) is an investigational drug not yet approved. TB-500 sold on research-chemical marketplaces is a synthetic fragment and is not an approved medicine. This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Hazard IdentificationClassification of the substance or mixture
no data available
GHS label elements, including precautionary statements
Pictogram(s) no data available Signal word no data available
Hazard statement(s) no data available
Precautionary statement(s) Prevention no data available
Response no data available
Storage no data available
Disposal no data available
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Tirzepatide,Semaglutide,Retatrutide,MOTS-C,GHK-CU,MT-2
-
Location:
203, NO. 88 Zhongxin North Road, Hangzhou Avenue Sub-district, Binhai New Area, Tianjin
-
Payment Terms:
TT against copy of documents,D/P,D/A,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
12
-
Total Annual Revenue:
$2.5 million-$5 million
-
Total Employees:
51-100
-
Year of Establishment:
2026
-
-
Inquiry History59 Inquiries
Country Product Purchase Quantity Date Posted
Malaysia
Peptide GHK-Cu Copper Tripeptide-1 Powder CAS 89030-95-5
10 MG Apr 24, 2025
Thailand
Copper Tripeptide-1
2 G Aug 3, 2026
United States
GHK-Cu
30 MG Aug 3, 2026
Philippines
GHK CU+KPV
10 PCS Jul 19, 2026
United States
Copper Tripeptide
10 MG Jul 14, 2026
United States
Klow
1 MT Jun 27, 2026
India
Copper Tripeptide-1GHK-Cu (CAS 89030-95-5)
5 KG Jun 22, 2026
Germany
Copper Tripeptide-1 (GHK-Cu)
20 G Jun 20, 2026
United States
GHK cu
1 MT May 19, 2026
China
GHK Cu
10000 Apr 21, 2026
China
GHK CU
500 MT Apr 14, 2026
Brazil
Tripeptídeo de cobre Ghk-Cu
100 MG Mar 25, 2026
Brazil
Ghk cu
1 KG Mar 18, 2026
United States
Ghk cu
1 MG Mar 6, 2026
Philippines
Copper Peptide 99% Blue powder
25 PCS Feb 21, 2026
United States
Ghk cu
10 MG Feb 12, 2026
Australia
GHKU
20 MT Jan 30, 2026
United States
GHK-Cu
1 G Jul 14, 2025
Malaysia
blue copper peptide GHK-Cu 98% Copper Tripeptide-1
10 MG Apr 24, 2025
India
GHK-cu peptide
100 MG Aug 9, 2024 Post an enquiry for this product